OC
AGN

Oakworth Capital’s Allergan plc AGN Stock Holding History

Oakworth Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-38
Closed -$7K – 608
2020
Q1 		$7K Hold
38
– – ﹤0.01% 414
2019
Q4 		$7K Hold
38
– – ﹤0.01% 465
2019
Q3 		$6K Sell
38
-15
-28% -$2.44K ﹤0.01% 480
2019
Q2 		$9K Sell
53
-88
-62% -$12.2K ﹤0.01% 497
2019
Q1 		$21K Hold
141
– – ﹤0.01% 385
2018
Q4 		$19K Buy
141
+15
+12% +$2.46K ﹤0.01% 386
2018
Q3 		$24K Hold
126
– – ﹤0.01% 378
2018
Q2 		$21K Buy
126
+10
+9% +$1.6K ﹤0.01% 390
2018
Q1 		$18K Sell
116
-22
-16% -$3.69K ﹤0.01% 385
2017
Q4 		$24K Sell
138
-187
-58% -$33.6K 0.01% 365
2017
Q3 		$75K Sell
325
-29
-8% -$6.74K 0.02% 250
2017
Q2 		$86K Hold
354
– – 0.02% 231
2017
Q1 		$85K Buy
354
+18
+5% +$4.19K 0.02% 231
2016
Q4 		$65K Sell
336
-15
-4% -$3.11K 0.02% 239
2016
Q3 		$81K Buy
351
+29
+9% +$7.09K 0.03% 209
2016
Q2 		$76K Hold
322
– – 0.03% 212
2016
Q1 		$86K Hold
322
– – 0.03% 175
2015
Q4 		$101K Hold
322
– – 0.04% 156
2015
Q3 		$88K Hold
322
– – 0.05% 117
2015
Q2 		$107K Hold
322
– – 0.05% 120
2015
Q1 		$91K Buy
322
+19
+6% +$5.42K 0.04% 156
2014
Q4 		$78K Hold
303
– – 0.04% 152
2014
Q3 		$69K Hold
303
– – 0.04% 116
2014
Q2 		$68K Sell
303
-51
-14% -$10.6K 0.04% 118
2014
Q1 		$73K Hold
354
– – 0.05% 115
2013
Q4 		$59K Buy
+354
New +$55.3K 0.04% 109

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Oakworth Capital's AGN Position: Q2 2020 in Review

Oakworth Capital sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 38 shares — an estimated $7K sold.

Oakworth Capital first reported a position in AGN in Q4 2013 and held it in 26 quarters. The position peaked at $107K in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Oakworth Capital reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Oakworth Capital sold 38 Allergan plc shares in Q2 2020, an estimated $7K.
  • Oakworth Capital first reported a position in Allergan plc in Q4 2013 and held it in 26 quarters.
  • Oakworth Capital's Allergan plc position peaked at $107K in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Oakworth Capital's 13F filing for Q2 2020, filed 11 Aug 2020.